Effect of Saindhavadi Anjana in Dry Eye Disease
- Conditions
- Health Condition 1: H578- Other specified disorders of eye and adnexa
- Registration Number
- CTRI/2024/03/064841
- Lead Sponsor
- one
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Signed ICF (Informed Consent Form)
Patients presenting with signs and symptoms of Shushkakshipaka
Patients presenting with signs of MGD
Ocular dryness
Meibomian gland orifice plugging
Lid margin telangiectasia
TBUT less than 5 seconds
Schirmer’s test less than 10mm
Cases complicated with acute, chronic, infective conjunctivitis or any specific eyelid disorder, corneal ulcer, dacryocystitis and lagophthalmos
Inflammatory diseases unrelated to MGD
Patients suffering from any systemic disorder or taking any medications which in the
opinion of PI may affect the clinical outcome of the trial
Contact lenses use
History of ocular surgery within 6 months prior to enrolment in trial
Pregnancy or child bearing age without contraception
Stevens-Johnson syndrome
Chemical, thermal or radiation injury
Sjogren’s syndrome
Patient who starts developing complications will be excluded from the study
Patient not willing for the treatment
Ongoing ocular or systemic infection
Ocular or periocular malignancy
Use of topical steroids, topical cyclosporine, topical anti-glaucoma medication within 60 days before screening
Lid structural abnormality not caused by MGD
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method